IRIS
PERRICONE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 55.179
EU - Europa 4.187
AS - Asia 2.832
SA - Sud America 212
AF - Africa 19
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 62.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 55.118
SG - Singapore 1.406
CN - Cina 761
DE - Germania 731
UA - Ucraina 692
IT - Italia 608
IE - Irlanda 577
FR - Francia 381
RU - Federazione Russa 363
HK - Hong Kong 264
GB - Regno Unito 250
SE - Svezia 219
BR - Brasile 193
KR - Corea 161
FI - Finlandia 159
BE - Belgio 58
JP - Giappone 44
PL - Polonia 40
CA - Canada 37
IR - Iran 29
UZ - Uzbekistan 28
IN - India 26
VN - Vietnam 25
NL - Olanda 24
ID - Indonesia 22
MX - Messico 20
AT - Austria 15
ES - Italia 13
AU - Australia 12
PK - Pakistan 11
CZ - Repubblica Ceca 10
RO - Romania 10
BD - Bangladesh 8
GR - Grecia 6
MY - Malesia 6
TR - Turchia 6
EC - Ecuador 5
KG - Kirghizistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AR - Argentina 4
EG - Egitto 4
EU - Europa 4
LT - Lituania 4
SI - Slovenia 4
UY - Uruguay 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DK - Danimarca 3
IL - Israele 3
IQ - Iraq 3
PH - Filippine 3
TW - Taiwan 3
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BJ - Benin 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 62.452
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.549
Wilmington 15.046
Houston 13.903
Fairfield 1.633
Ann Arbor 1.431
Chandler 1.084
Singapore 958
Ashburn 800
Seattle 629
Jacksonville 585
Cambridge 538
Dublin 510
Medford 418
New York 268
Hong Kong 262
Beijing 255
Santa Clara 209
Lawrence 196
Dearborn 192
Rome 174
The Dalles 156
Zhengzhou 124
Moscow 83
Menlo Park 79
San Diego 74
Mülheim 71
Redwood City 70
Boardman 55
Brussels 52
Milan 47
Nanjing 46
Falls Church 41
Norwalk 40
Council Bluffs 39
Palo Alto 39
Shanghai 39
Kraków 36
Seoul 36
London 35
Mountain View 30
Hefei 29
Kunming 27
Los Angeles 27
Chengdu 26
San Mateo 26
Verona 26
Toronto 24
University Park 24
Helsinki 22
Guangzhou 21
Nuremberg 19
Jakarta 17
Dong Ket 16
Munich 16
São Paulo 16
Augusta 15
Shenzhen 14
Jinan 13
Phoenix 13
Bassano del Grappa 12
Scottsdale 12
Chicago 11
Esslingen am Neckar 11
Nürnberg 11
Saint Petersburg 10
Brno 9
Detroit 9
Las Vegas 9
Leawood 9
North Bergen 9
Ardabil 8
Bologna 8
Nanchang 8
Napoli 8
Padova 8
San Francisco 8
Hounslow 7
Indiana 7
Kilburn 7
Redmond 7
Tokyo 7
Wuhan 7
Amsterdam 6
Fuzhou 6
Hangzhou 6
Hanoi 6
Mexico City 6
Peshawar 6
Acton 5
Belo Horizonte 5
Cangzhou 5
Changsha 5
Dallas 5
Naples 5
Perugia 5
Saint Louis 5
Shenyang 5
Williamsburg 5
Aversa 4
Brisbane 4
Totale 56.519
Salva come PNG Salva come JPEG
Nome #
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 492
Gonadal mosaicism in hereditary angioedema 485
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 460
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 455
Complement and autoimmunity 453
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 452
Denaturing HPLC in laboratory diagnosis of hereditary angioedema 450
Vasculitides and the Complement System: a Comprehensive Review 448
NK cells in autoimmunity: A two-edg'd weapon of the immune system 441
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 441
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 440
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 439
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 436
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 436
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 435
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 435
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 435
Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission? 434
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 431
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 430
Glutathione: A key player in autoimmunity 427
Apremilast for the treatment of psoriasis. 427
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 426
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 426
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 425
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 423
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 423
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 422
High-dose intravenous immunoglobulin treatment activates complement in vivo 421
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 420
Evidence of impaired sense of smell in hereditary angioedema 419
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 417
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 417
Autoantibodies in inflammatory arthritis 415
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: The experience of two Italian integrated Dermatology/Rheumatology outpatient clinics 414
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 414
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 413
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 411
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group 411
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. 410
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 410
Complement activation and sensitizing antibodies in lyme borreliosis - a microbial adherence immobilization assay for borrelia-burgdorferi (maia-bb) 410
Adalimumab and polymyalgia rheumatica. clinical remission but persisting high levels of esr: a controversy 406
HELLP syndrome: A complication or a new autoimmune syndrome? 404
The type I IFN system in rheumatoid arthritis 403
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 403
Occurrence of localized scleroderma morphea in a patient with rheumatoid arthritis treated with etanercept 403
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 403
GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment 401
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 401
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 401
European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT 400
The European register of hereditary angioedema: Experience and preliminary results 400
Successful high dose intravenous immunoglobulin treatment of a pregnant patient affected with hypereosinophilia syndrome and antiphospholipid syndrome (aPL plus recurrent spontaneous abortion) 396
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 396
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 396
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis 394
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 394
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 393
TREATMENT OF RECURRENT SPONTANEOUS ABORTION WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN 391
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication 391
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 390
Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis 390
Behcet's disease and etanercept: eighty weeks of experience 390
The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies 390
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 390
Antimyocardial Autoantibodies (AMCA) 389
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 388
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 387
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity 385
Auto-reactions, autoimmunity and psoriatic arthritis 383
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 382
Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. 382
ADA genetic polymorphism and total plasma IgE level in healthy adults 381
Small-medium vessel vasculitides: Is the complement system a potential forgotten target? 381
BETA ENDORPHIN INTERACTION WITH LFA 1 (CD11A/CD18) ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES 378
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects 378
Discontinuation of anti-TNFα therapy due to remission in rheumatoid arthritis: A retrospective study 377
Cystic ovaries in women affected with hereditary angioedema. 376
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 376
The interplay between inflammation and metabolism in rheumatoid arthritis 376
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 376
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 375
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab 375
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 373
Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy 373
Serum thymosin alpha 1 levels in normal and pathological conditions 372
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 371
NK cells, autoantibodies, and immunologic infertility: a complex interplay 370
Insights on the role of physical activity in patients with rheumatoid arthritis 369
Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines 368
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 367
C1 Inhibitor Autoantibodies 367
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 366
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 365
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways 364
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 364
Cytokine production by human fetal membranes and uterine decidua at term gestation in relation to labor 363
Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS) 363
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts 362
Totale 40.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.656 0 0 0 0 0 0 0 0 0 1.455 1.073 1.128
2020/202110.891 1.225 1.298 1.193 1.269 1.218 1.144 1.340 1.126 359 240 382 97
2021/20222.080 108 221 157 118 84 128 101 99 101 198 180 585
2022/20232.657 241 230 97 369 252 582 205 162 264 39 154 62
2023/20241.028 132 41 48 35 85 317 29 106 19 26 16 174
2024/20253.369 181 984 494 275 105 308 215 185 436 186 0 0
Totale 63.188